Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. Novartis and Gilead hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast period. Based on the drug class the market can be segmented into Beta blockers, ARBs, and ACE inhibitors. Angiotensin II receptor blockers (ARB) are a group of pharmaceuticals that modify the renin-angiotensin system. The heart disease drugs market is experiencing growth in the ARBs segment because it reduces the risk of death caused by heart failure and minimizes the chance of hospitalization of people with heart failure.
The latest trend gaining momentum in the market is investment inclination toward developing countries. Countries such as India, China, and Brazil are turning out to be some of the most attractive countries for pharmaceutical companies across the globe. Many factors such as huge share of global population and rising geriatric population are leading to the high growth of healthcare sector in the developing countries. In addition, the rising cases of lifestyle disorders such as obesity and diabetes also contribute to higher heart failure cases in the region.One of the major drivers for this market is rising geriatric population. A large number of health problems are associated with the rising age, and CVDs are major among them. As a person gets older, the blood vessels become less flexible, thus making it difficult for the blood to flow through them. Rising age accompanied by other factors such as lifestyle-oriented diseases and smoking increases the risk of CVDs, especially heart failure. Heart failure in the geriatric population will continue to be a rising health burden globally, as this population represents the majority of the heart failure patients. Hence, rising geriatric population drives the demand for heart failure drugs during the forecast period.
This report elaborates on the current development of the Heart Failure Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Bayer
Novartis
Amgen
Gilead
Pfizer
AstraZeneca
GlaxoSmithKline
Teva Pharmaceutical industries
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Beta Blockers
ARBs
ACE Inhibitors
Application:
Hospital
Pharmacy
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Heart Failure Drugs Industry Overview
-
1.1.1 Heart Failure Drugs Market Scope and Market Segments
-
1.1.2 Heart Failure Drugs Industry Characteristics
-
1.1.3 Global and China Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Heart Failure Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Heart Failure Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Beta Blockers
-
1.2.2 ARBs
-
1.2.3 ACE Inhibitors
-
1.3 Global Heart Failure Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Pharmacy
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Heart Failure Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Heart Failure Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Heart Failure Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Heart Failure Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Heart Failure Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Heart Failure Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Heart Failure Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Heart Failure Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Heart Failure Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Heart Failure Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Heart Failure Drugs Industry PEST Analysis
-
2.3 Heart Failure Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Heart Failure Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Heart Failure Drugs Industry
Chapter 3 Global and China Heart Failure Drugs Market, by Manufacturer
-
3.1 Global and China Heart Failure Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Heart Failure Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Heart Failure Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Heart Failure Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Heart Failure Drugs Market Top 3 Players
Chapter 4 Global and China Heart Failure Drugs Market, by Type (2017-2028)
-
4.1 Heart Failure Drugs Market Trend, by Type
-
4.2 Global Heart Failure Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Heart Failure Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Heart Failure Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Heart Failure Drugs Price Trend, by Type (2017-2028)
-
4.3 China Heart Failure Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Heart Failure Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Heart Failure Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Heart Failure Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Heart Failure Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Heart Failure Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Heart Failure Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Heart Failure Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Heart Failure Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Heart Failure Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Heart Failure Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Heart Failure Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Heart Failure Drugs Market Analysis
-
7.1 North America Heart Failure Drugs Market, by Type
-
7.2 North America Heart Failure Drugs Market, by Application
-
7.3 North America Heart Failure Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Heart Failure Drugs Market Analysis
-
8.1 Europe Heart Failure Drugs Market, by Type
-
8.2 Europe Heart Failure Drugs Market, by Application
-
8.3 Europe Heart Failure Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Heart Failure Drugs Market Analysis
-
9.1 APAC Heart Failure Drugs Market, by Type
-
9.2 APAC Heart Failure Drugs Market, by Application
-
9.3 APAC Heart Failure Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Heart Failure Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Heart Failure Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Heart Failure Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Heart Failure Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Heart Failure Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Heart Failure Drugs Company Profiles
-
11.1 Bayer
-
11.1.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Bayer Heart Failure Drugs Product Profiles, Application and Specification
-
11.1.3 Bayer Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Novartis
-
11.2.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Novartis Heart Failure Drugs Product Profiles, Application and Specification
-
11.2.3 Novartis Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Amgen
-
11.3.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Amgen Heart Failure Drugs Product Profiles, Application and Specification
-
11.3.3 Amgen Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Gilead
-
11.4.1 Gilead Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Gilead Heart Failure Drugs Product Profiles, Application and Specification
-
11.4.3 Gilead Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Pfizer
-
11.5.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Pfizer Heart Failure Drugs Product Profiles, Application and Specification
-
11.5.3 Pfizer Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 AstraZeneca
-
11.6.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 AstraZeneca Heart Failure Drugs Product Profiles, Application and Specification
-
11.6.3 AstraZeneca Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 GlaxoSmithKline
-
11.7.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 GlaxoSmithKline Heart Failure Drugs Product Profiles, Application and Specification
-
11.7.3 GlaxoSmithKline Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Teva Pharmaceutical industries
-
11.8.1 Teva Pharmaceutical industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Teva Pharmaceutical industries Heart Failure Drugs Product Profiles, Application and Specification
-
11.8.3 Teva Pharmaceutical industries Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Heart Failure Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Heart Failure Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Heart Failure Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Heart Failure Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Heart Failure Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Heart Failure Drugs Market Size and Growth Rate of Beta Blockers (2017-2028)
-
Figure Global Heart Failure Drugs Market Size and Growth Rate of ARBs (2017-2028)
-
Figure Global Heart Failure Drugs Market Size and Growth Rate of ACE Inhibitors (2017-2028)
-
Figure Global Heart Failure Drugs Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Heart Failure Drugs Market Size and Growth Rate of Pharmacy (2017-2028)
-
Figure Global Heart Failure Drugs Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Heart Failure Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Heart Failure Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Heart Failure Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Heart Failure Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Heart Failure Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Heart Failure Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Heart Failure Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Heart Failure Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Heart Failure Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Heart Failure Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Heart Failure Drugs Market Share, by Manufacturer in 2022
-
Table Global Heart Failure Drugs Sales Volume, by Type (2017-2028)
-
Table Global Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Heart Failure Drugs Sales Value, by Type (2017-2028)
-
Table Global Heart Failure Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Heart Failure Drugs Price Trend, by Type (2017-2028)
-
Table China Heart Failure Drugs Sales Volume, by Type (2017-2028)
-
Table China Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Heart Failure Drugs Sales Value, by Type (2017-2028)
-
Table China Heart Failure Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Heart Failure Drugs Price Trend, by Type (2017-2028)
-
Table Global Heart Failure Drugs Sales Volume, by Application (2017-2028)
-
Table Global Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Heart Failure Drugs Sales Value, by Application (2017-2028)
-
Table Global Heart Failure Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Heart Failure Drugs Sales Value Share, by Application (2017-2028)
-
Table China Heart Failure Drugs Sales Volume, by Application (2017-2028)
-
Table China Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Heart Failure Drugs Sales Value, by Application (2017-2028)
-
Table China Heart Failure Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Heart Failure Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Heart Failure Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Heart Failure Drugs Sales Volume, by Type (2017-2028)
-
Table North America Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Heart Failure Drugs Sales Volume, by Application (2017-2028)
-
Table North America Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Heart Failure Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Heart Failure Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Heart Failure Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Heart Failure Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Heart Failure Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Heart Failure Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Heart Failure Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Heart Failure Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Heart Failure Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Heart Failure Drugs Sales Value and Growth Rate (2017-2028)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gilead Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gilead Product Profiles, Application and Specification
-
Table Gilead Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Product Profiles, Application and Specification
-
Table GlaxoSmithKline Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Pharmaceutical industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Pharmaceutical industries Product Profiles, Application and Specification
-
Table Teva Pharmaceutical industries Heart Failure Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
